Variant report

Variant	esv14191
Chromosome Location	chr16:31399979-31415153
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BHLHE40	chr16:31405046-31405194	K562	blood:	n/a	chr16:31405138-31405159 chr16:31405145-31405154
2	CBX3	chr16:31411108-31411433	K562	blood:	n/a	n/a
3	CBX3	chr16:31411149-31411357	K562	blood:	n/a	n/a
4	CEBPB	chr16:31414054-31414279	Hela-S3	cervix:	n/a	n/a
5	CEBPB	chr16:31414078-31414184	IMR90	lung:	n/a	n/a
6	CHD2	chr16:31404515-31404700	GM12878	blood:	n/a	n/a
7	CHD2	chr16:31409229-31409240	Hela-S3	cervix:	n/a	n/a
8	CTCF	chr16:31400872-31400918	A549	lung:	n/a	n/a
9	CTCF	chr16:31400886-31400929	MCF-7	breast:	n/a	n/a
10	CTCF	chr16:31400840-31400958	MCF-7	breast:	n/a	n/a
11	CTCF	chr16:31400855-31400943	LNCaP	prostate:	n/a	n/a
12	CTCF	chr16:31406638-31406660	Spleen_OC	spleen:	n/a	n/a
13	CTCF	chr16:31400800-31400950	MCF-7	breast:	n/a	n/a
14	CTCF	chr16:31400844-31400948	MCF-7	breast:	n/a	n/a
15	CTCF	chr16:31400740-31400890	HCT-116	colon:	n/a	n/a
16	CTCF	chr16:31400836-31400943	MCF-7	breast:	n/a	n/a
17	CTCF	chr16:31400858-31400940	MCF-7	breast:	n/a	n/a
18	EBF1	chr16:31411640-31411821	GM12878	blood:	n/a	n/a
19	ELF1	chr16:31404522-31405102	GM12878	blood:	n/a	n/a
20	FOS	chr16:31414048-31414361	MCF10A-Er-Src	breast:	n/a	n/a
21	FOS	chr16:31414074-31414328	MCF10A-Er-Src	breast:	n/a	n/a
22	FOS	chr16:31414051-31414384	MCF10A-Er-Src	breast:	n/a	n/a
23	FOS	chr16:31414040-31414399	MCF10A-Er-Src	breast:	n/a	n/a
24	FOSL1	chr16:31414003-31414369	K562	blood:	n/a	n/a
25	FOSL2	chr16:31413942-31414447	SK-N-SH	brain:	n/a	n/a
26	FOSL2	chr16:31413990-31414419	MCF-7	breast:	n/a	n/a
27	GATA3	chr16:31413897-31414655	SK-N-SH	brain:	n/a	n/a
28	GATA3	chr16:31413993-31414604	MCF-7	breast:	n/a	n/a
29	GATA3	chr16:31413919-31414553	SK-N-SH	brain:	n/a	n/a
30	HMGN3	chr16:31408785-31408816	K562	blood:	n/a	n/a
31	JUND	chr16:31413930-31414505	SK-N-SH	brain:	n/a	chr16:31414493-31414505
32	JUND	chr16:31414063-31414312	K562	blood:	n/a	n/a
33	MAFF	chr16:31401966-31402367	K562	blood:	n/a	chr16:31402121-31402139
34	MAFF	chr16:31401953-31402374	HepG2	liver:	n/a	chr16:31402121-31402139
35	MAFK	chr16:31402006-31402365	Hela-S3	cervix:	n/a	chr16:31402177-31402194 chr16:31402123-31402138
36	MAFK	chr16:31401953-31402372	IMR90	lung:	n/a	chr16:31402177-31402194 chr16:31402123-31402138
37	MAFK	chr16:31401965-31402387	K562	blood:	n/a	chr16:31402177-31402194 chr16:31402123-31402138
38	MAFK	chr16:31402030-31402299	H1-hESC	embryonic stem cell:	n/a	chr16:31402177-31402194 chr16:31402123-31402138
39	MAFK	chr16:31401954-31402371	HepG2	liver:	n/a	chr16:31402177-31402194 chr16:31402123-31402138
40	MAFK	chr16:31401932-31402370	GM12878	blood:	n/a	chr16:31402177-31402194 chr16:31402123-31402138
41	MAFK	chr16:31401951-31402363	HepG2	liver:	n/a	chr16:31402177-31402194 chr16:31402123-31402138
42	MAX	chr16:31411402-31411949	NB4	blood:	n/a	n/a
43	MAX	chr16:31412879-31413088	HepG2	liver:	n/a	chr16:31412887-31412898 chr16:31412887-31412898 chr16:31412888-31412897 chr16:31412879-31412895 chr16:31412887-31412897 chr16:31412888-31412897 chr16:31412887-31412898 chr16:31412889-31412896
44	MAX	chr16:31412653-31413144	SK-N-SH	brain:	n/a	chr16:31412887-31412898 chr16:31412887-31412898 chr16:31412888-31412897 chr16:31412879-31412895 chr16:31412887-31412897 chr16:31412888-31412897 chr16:31412887-31412898 chr16:31412889-31412896
45	MAX	chr16:31412799-31413114	ECC-1	luminal epithelium:	n/a	chr16:31412887-31412898 chr16:31412887-31412898 chr16:31412888-31412897 chr16:31412879-31412895 chr16:31412887-31412897 chr16:31412888-31412897 chr16:31412887-31412898 chr16:31412889-31412896
46	MAX	chr16:31412733-31413109	MCF-7	breast:	n/a	chr16:31412887-31412898 chr16:31412887-31412898 chr16:31412888-31412897 chr16:31412879-31412895 chr16:31412887-31412897 chr16:31412888-31412897 chr16:31412887-31412898 chr16:31412889-31412896
47	MAX	chr16:31412887-31413115	H1-hESC	embryonic stem cell:	n/a	chr16:31412887-31412898 chr16:31412887-31412898 chr16:31412888-31412897 chr16:31412887-31412897 chr16:31412888-31412897 chr16:31412887-31412898 chr16:31412889-31412896
48	MAZ	chr16:31414965-31414972	Hela-S3	cervix:	n/a	n/a
49	MYC	chr16:31414057-31414400	MCF10A-Er-Src	breast:	n/a	n/a
50	MYC	chr16:31411478-31411902	NB4	blood:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr16:31404385-31404435	HCT-116	colon:	n/a
2	chr16:31408712-31408762	Hela-S3	cervix:	n/a
3	chr16:31405101-31405151	GM12878	blood:	n/a
4	chr16:31408900-31408950	HPAEpiC	pulmonary alveolar:	n/a
5	chr16:31408867-31408917	SK-N-MC	brain:	n/a
6	chr16:31408898-31408948	K562	blood:	n/a
7	chr16:31415135-31415185	GM12891	blood:	n/a
8	chr16:31408712-31408762	AG10803	skin:	n/a
9	chr16:31405101-31405151	HCPEpiC	choroid plexus:	n/a
10	chr16:31404385-31404435	HL-60	blood:	n/a
11	chr16:31405101-31405151	Hela-S3	cervix:	n/a
12	chr16:31408712-31408762	Hepatocyte	liver:	n/a
13	chr16:31408867-31408917	HRPEpiC	eye:	n/a
14	chr16:31408712-31408762	GM12878	blood:	n/a
15	chr16:31403683-31403733	HIPEpiC	eye:	n/a
16	chr16:31408900-31408950	SK-N-SH_RA	brain:	n/a
17	chr16:31403683-31403733	U87	brain:	n/a
18	chr16:31403683-31403733	NH-A	brain:	n/a
19	chr16:31408898-31408948	SAEC	small airway:	n/a
20	chr16:31408898-31408948	AG04450	lung:	fetal
21	chr16:31408712-31408762	SAEC	small airway:	n/a
22	chr16:31404385-31404435	AG09309	skin:	n/a
23	chr16:31408712-31408762	MCF-7	breast:	n/a
24	chr16:31405101-31405151	SK-N-SH_RA	brain:	n/a
25	chr16:31408867-31408917	HCM	heart:	n/a
26	chr16:31408867-31408917	HEK293	kidney:	embryo
27	chr16:31405101-31405151	ProgFib	skin:	n/a
28	chr16:31415135-31415185	HCPEpiC	choroid plexus:	n/a
29	chr16:31408898-31408948	AG09319	gingival:	n/a
30	chr16:31415135-31415185	AG04450	lung:	fetal
31	chr16:31408712-31408762	LNCaP	prostate:	n/a
32	chr16:31403683-31403733	AG10803	skin:	n/a
33	chr16:31408867-31408917	GM06990	blood:	n/a
34	chr16:31405101-31405151	MCF10A-Er-Src	breast:	n/a
35	chr16:31415135-31415185	HRPEpiC	eye:	n/a
36	chr16:31408867-31408917	GM12892	blood:	n/a
37	chr16:31408712-31408762	HIPEpiC	eye:	n/a
38	chr16:31408712-31408762	HAEpiC	amniotic membrane:	n/a
39	chr16:31415135-31415185	ECC-1	luminal epithelium:	n/a
40	chr16:31405101-31405151	NB4	blood:	n/a
41	chr16:31404385-31404435	SAEC	small airway:	n/a
42	chr16:31408867-31408917	CMK	blood:	n/a
43	chr16:31408898-31408948	HCPEpiC	choroid plexus:	n/a
44	chr16:31404385-31404435	HPAEpiC	pulmonary alveolar:	n/a
45	chr16:31415135-31415185	NB4	blood:	n/a
46	chr16:31408867-31408917	Caco-2	colon:	n/a
47	chr16:31405101-31405151	RPTEC	kidney:	n/a
48	chr16:31403683-31403733	ProgFib	skin:	n/a
49	chr16:31403683-31403733	MCF10A-Er-Src	breast:	n/a
50	chr16:31403683-31403733	NT2-D1	testis:	n/a

No.	Distal block	Cell Line	Cell type
1	chr16:31407031..31409416-chr16:31465348..31468192,2	MCF-7	breast:
2	chr16:31404071..31406519-chr16:31413482..31415617,2	K562	blood:
3	chr16:31408712..31410722-chr16:31883758..31886436,2	K562	blood:
4	chr16:31405158..31408011-chr16:31425171..31426679,2	MCF-7	breast:
5	chr16:31403402..31405876-chr16:31406306..31408936,2	MCF-7	breast:
6	chr16:31191136..31192870-chr16:31404226..31406023,2	MCF-7	breast:
7	chr16:31397034..31399746-chr16:31400566..31403518,3	MCF-7	breast:
8	chr16:31400836..31402888-chr16:31406431..31408279,2	MCF-7	breast:
9	chr16:31414435..31419605-chr16:31467873..31472757,5	K562	blood:
10	chr16:31404071..31406519-chr16:31413482..31415617,2	K562	blood:
11	chr16:31409305..31411632-chr16:31412830..31415079,2	K562	blood:
12	chr16:31370070..31372965-chr16:31413920..31417255,3	K562	blood:
13	chr16:31400836..31402888-chr16:31406431..31408279,2	MCF-7	breast:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-ITGAX-1	chr16:31414558-31416020	ENSG00000260757.1
2	lnc-ITGAX-1	chr16:31413886-31414189	ENSG00000260757.1

Variant related genes	Relation type
ENSG00000260757	TF binding region
ITGAD	TF binding region
ENSG00000260757	CpG island
ITGAD	CpG island
ENSG00000260757	chromatin interactions
ENSG00000185947	chromatin interactions
ENSG00000156886	chromatin interactions
ENSG00000089280	chromatin interactions
ENSG00000260267	chromatin interactions
ENSG00000140691	chromatin interactions
ENSG00000140678	chromatin interactions

Extended variants
information (count: 569 )
Associated
traits (count: 120 )

Variant overlapped rSNPs/rCNVs (count:569 , 50 per page) page: 1 2 3 4 5 6 7 ... 12

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs142216830	chr16:31400140-31400141	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs71151483	chr16:31400184-31400185	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs539673294	chr16:31400186-31400187	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs146371880	chr16:31400248-31400249	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs377316791	chr16:31400289-31400290	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs538746055	chr16:31400315-31400316	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs59381569	chr16:31400352-31400353	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
8	rs9930811	chr16:31400360-31400361	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
9	rs112822326	chr16:31400380-31400381	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs536866509	chr16:31400384-31400385	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs116311864	chr16:31400456-31400457	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs560322261	chr16:31400509-31400510	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs375702898	chr16:31400546-31400547	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs572367689	chr16:31400548-31400549	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs547185933	chr16:31400560-31400561	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs557918756	chr16:31400584-31400585	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs182802135	chr16:31400607-31400608	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs371222713	chr16:31400625-31400626	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs142133957	chr16:31400648-31400649	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs369665106	chr16:31400652-31400653	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs150744056	chr16:31400657-31400658	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs562254847	chr16:31400690-31400691	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs188627297	chr16:31400691-31400692	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs12325629	chr16:31400701-31400702	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs192999317	chr16:31400724-31400725	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs139067319	chr16:31400727-31400728	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs552475312	chr16:31400759-31400760	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs149880838	chr16:31400765-31400766	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs552028183	chr16:31400786-31400787	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs563187278	chr16:31400814-31400815	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs145508326	chr16:31400824-31400825	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs371089019	chr16:31400826-31400827	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs537888537	chr16:31400833-31400834	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs28475637	chr16:31400899-31400900	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs570561094	chr16:31400959-31400960	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs183700143	chr16:31400980-31400981	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs553918359	chr16:31401115-31401116	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs572333212	chr16:31401150-31401151	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs546163049	chr16:31401238-31401239	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs564837581	chr16:31401263-31401264	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs377128670	chr16:31401302-31401303	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs188624541	chr16:31401303-31401304	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs543751839	chr16:31401409-31401410	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs147553245	chr16:31401441-31401442	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs535236335	chr16:31401480-31401481	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs529374839	chr16:31401583-31401584	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs547936196	chr16:31401586-31401587	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs560370145	chr16:31401638-31401639	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs527517878	chr16:31401667-31401668	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs192575676	chr16:31401693-31401694	Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:120)

Disease	PMID	Source
Hodgkin''s lymphoma	20651079	CNVD
Metanephric adenoma	20802469	CNVD
Melanoma	18172304	CNVD
Breast cancer	16608533	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Lung adenocarcinoma	17086460	CNVD
Lung cancer	17086460	CNVD
Autism	22566537	CNVD
Intellectual disability	22566537	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Endometrial cancer	22040021	CNVD
Ewing''s sarcoma	21437220	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	17603634	CNVD
Breast cancer	21264507	CNVD
Cervical cancer	21063398	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Autism	19415332	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Schizophrenia	22958593	CNVD
Lung cancer	18438408	CNVD
Ductal carcinoma	22052326	CNVD
Breast cancer	21509527	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Autism	22495311	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Hodgkin''s lymphoma	17606441	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	21858162	CNVD
Hepatocellular carcinoma	16750200	CNVD
Mental retardation	19951919	CNVD
Colorectal cancer	16272173	CNVD
Bladder cancer	21909424	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	21785460	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Breast cancer	21990379	CNVD
Astrocytoma	22246337	CNVD
Myelofibrosis	22110671	CNVD
Epilepsy	22499536	CNVD
Attention deficit hyperactivity disorder	21324949	CNVD
Austim spectrum disorder	21302340	CNVD
Autism	22513405	CNVD
Autism	22958593	CNVD
Autism	18184952	CNVD
Autism	19966786	CNVD
Autism	21394203	CNVD
Autism	21969575	CNVD
Autism	22241247	CNVD
Autism	20970697	CNVD
Autism	20942916	CNVD
Epilepsy	20970697	CNVD
Intellectual disability	22045946	CNVD
Mental retardation	19966786	CNVD
Developmental delay	20808231	CNVD
Obesity	20808231	CNVD
Autism	18923514	CNVD
Obesity	21881559	CNVD
Obesity	21956041	CNVD
Autism	20659124	CNVD
Mental retardation	21062444	CNVD
Schizophrenia	20587603	CNVD
Schizophrenia	21285140	CNVD
Schizophrenia	22885689	CNVD
Schizophrenia	20553308	CNVD
Schizophrenia	20970697	CNVD
Schizophrenia	20433910	CNVD
Schizophrenia	22241247	CNVD
Autism	19242545	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Intracranial ependymoma	16609018	CNVD
Schizophrenia	21399695	CNVD
Autism	21956041	CNVD
Disorders of sex development	21048976	CNVD
Autism	22067053	CNVD
Autism	18156158	CNVD
Mental retardation	20152051	CNVD
Autism	19218893	CNVD
Autism	21289514	CNVD
Schizophrenia	19855392	CNVD
neurodevelopmental Syndrome	20503337	CNVD
Benign familial neonatal-infantile seizures	21060786	CNVD
Low-grade fibromyxoid sarcoma	0	CNVD
Cancer	21183584	CNVD
Low-grade fibromyxoid sarcoma	21536545	CNVD
Breast cancer	21045282	CNVD
Neuroblastoma	20406844	CNVD
Autism	19050728	CNVD
Epilepsy	20923578	CNVD
Psychiatric disorder	19050728	CNVD
Schizophrenia	19348701	CNVD
Attention deficit hyperactivity disorder	19097825	CNVD
Autism	20964600	CNVD
Schizophrenia	19955444	CNVD
Schizophrenia	18990708	CNVD
Schizophrenia	19571808	CNVD
Breast cancer	20409316	CNVD
Severe combined immunodeficiency	19097825	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Autism	18522746	CNVD
Urothelial carcinoma	21177765	CNVD
Chronic myeloid leukemia	21384125	CNVD
Prostate cancer	18632612	CNVD
Sezary syndrome	18413736	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:123 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr16:31343000-31400800	Weak transcription	Right Atrium	heart
2	chr16:31395000-31406800	Weak transcription	Primary monocytes fromperipheralblood	blood
3	chr16:31398200-31403600	Weak transcription	Primary hematopoietic stem cells short term culture	blood
4	chr16:31398600-31404000	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
5	chr16:31398600-31404400	Weak transcription	A549	lung
6	chr16:31400800-31401000	Enhancers	Right Atrium	heart
7	chr16:31403600-31409400	Enhancers	Primary hematopoietic stem cells short term culture	blood
8	chr16:31404000-31404800	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
9	chr16:31404000-31405200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
10	chr16:31404200-31404400	Weak transcription	Primary hematopoietic stem cells	blood
11	chr16:31404200-31404800	Enhancers	ES-I3 Cell Line	embryonic stem cell
12	chr16:31404200-31404800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
13	chr16:31404200-31405000	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
14	chr16:31404200-31405000	Enhancers	GM12878-XiMat	blood
15	chr16:31404200-31405200	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
16	chr16:31404400-31404600	Enhancers	A549	lung
17	chr16:31404400-31404800	Enhancers	H9 Cell Line	embryonic stem cell
18	chr16:31404400-31404800	Enhancers	iPS-18 Cell Line	embryonic stem cell
19	chr16:31404400-31405200	Enhancers	H1 Cell Line	embryonic stem cell
20	chr16:31404400-31405200	Enhancers	Primary hematopoietic stem cells	blood
21	chr16:31404600-31404800	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
22	chr16:31404600-31410000	Weak transcription	A549	lung
23	chr16:31404800-31406200	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
24	chr16:31404800-31406800	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
25	chr16:31405200-31406800	Weak transcription	Primary hematopoietic stem cells	blood
26	chr16:31405200-31406800	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
27	chr16:31405200-31408600	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
28	chr16:31406200-31411000	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
29	chr16:31406800-31407000	Enhancers	Primary hematopoietic stem cells	blood
30	chr16:31406800-31407600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
31	chr16:31406800-31407600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
32	chr16:31406800-31409200	Enhancers	Monocytes-CD14+_RO01746	blood
33	chr16:31406800-31412800	Enhancers	Primary monocytes fromperipheralblood	blood
34	chr16:31407000-31407200	Enhancers	Primary neutrophils fromperipheralblood	blood
35	chr16:31407000-31407200	Enhancers	Gastric	stomach
36	chr16:31407000-31407400	Weak transcription	Primary hematopoietic stem cells	blood
37	chr16:31407200-31410000	Weak transcription	Primary neutrophils fromperipheralblood	blood
38	chr16:31407200-31410000	Weak transcription	Gastric	stomach
39	chr16:31407400-31407600	Enhancers	Primary hematopoietic stem cells	blood
40	chr16:31407600-31410200	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
41	chr16:31407600-31410400	Weak transcription	Primary hematopoietic stem cells	blood
42	chr16:31407600-31410400	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
43	chr16:31408600-31408800	Enhancers	ES-I3 Cell Line	embryonic stem cell
44	chr16:31408600-31409000	Bivalent Enhancer	Fetal Muscle Trunk	muscle
45	chr16:31408600-31409400	Enhancers	ES-WA7 Cell Line	embryonic stem cell
46	chr16:31408600-31409400	Enhancers	HUES6 Cell Line	embryonic stem cell
47	chr16:31408600-31409400	Genic enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
48	chr16:31408600-31409600	Enhancers	Fetal Adrenal Gland	Adrenal Gland
49	chr16:31409200-31409600	Weak transcription	Monocytes-CD14+_RO01746	blood
50	chr16:31409200-31414000	Weak transcription	Hela-S3	cervix

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links